secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001193125-24-240757
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Royalty acquires 50% of Twist Bioscience's royalty/milestone economics for $15M
--------------------------------------------------------------------------------

- Acquired 50% economic interest in milestones/royalties from Twist's 60+ early-stage programs across 30 partners for $15M upfront.
- XOMA's portfolio now exceeds 100 assets, spanning commercial to pre-clinical programs.
- Twist's Biopharma Solutions business unit yields future payments under biopharma services agreements.
- Chief Investment Officer Brad Sitko cites potential for superior risk-adjusted returns.
- Gibson, Dunn & Crutcher served as XOMA's legal advisor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312524240757/0001193125-24-240757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312524240757/d826403d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-240757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer